BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Submission of Matters to a Vote of Security Holders

ITEM 5.07

Submission of Matters to a Vote of Security Holders.
Bio-Rad Laboratories, Inc. (the Company) held its Annual Meeting
of Stockholders on April 25, 2017. The matters voted upon at the
meeting and the results of those votes are set forth below.
1. Each of the nominated directors was elected and
received the affirmative vote of a majority of the
votes cast in the respective class of Common Stock, as
follows:
Class of
Common Stock
Votes
Votes
Votes
Broker
to Elect
For
Against
Abstaining
Non-Votes
Melinda Litherland
Class A
19,962,061
345,415
3,151
2,064,610
Arnold A. Pinkston
Class A
19,963,761
343,155
3,711
2,064,610
Jeffrey L. Edwards
Class B
4,930,264
115,341
Gregory K. Hinckley
Class B
4,930,178
–
115,341
Alice N. Schwartz
Class B
4,923,164
7,649
–
115,341
Norman Schwartz
Class B
4,922,965
7,848
–
115,341
2. The proposal to ratify the selection of KPMG LLP as
the Companys independent auditors for the fiscal year
ending December 31, 2017 was ratified and received the
affirmative vote of a majority of the voting power of the
holders of Class A and Class B Common Stock, as follows:
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
7,279,650
3,560
–
3. The proposal to approve the Bio-Rad Laboratories, Inc.
2017 Incentive Award Plan was approved and received the
affirmative vote of a majority of the voting power of the
holders of Class A and Class B Common Stock, as follows:
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
6,030,772
927,471
3,633
321,802
4. The proposal to approve an amendment to the Bio-Rad
Laboratories, Inc. 2011 Employee Stock Purchase Plan to
increase the number of shares authorized thereunder by
700,000 was approved and received the affirmative vote of
a majority of the voting power of the holders of Class A
and Class B Common Stock, as follows:
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
6,958,695
2,568
321,802
5. The non-binding advisory vote to approve executive
compensation was approved and received the affirmative
vote of a majority of the voting power of the holders of
Class A and Class B Common Stock, as follows:
Votes
Votes
Votes
Broker
For
Against
Abstaining
Non-Votes
6,894,740
63,091
4,045
321,802
6. With respect to the non-binding advisory vote on the
frequency of future advisory votes to approve executive
compensation, Three Years received the affirmative vote
of a majority of the voting power of the holders of Class
A and Class B Common Stock, as follows:
Votes
Votes
Votes
Votes
Broker
1 Year
2 Years
3 Years
Abstaining
Non-Votes
1,151,180
2,091
5,806,177
2,428
321,802
Consistent with the preferred frequency expressed by the
Company’s stockholders and the determination of the
Companys Board of Directors, the Company has determined
that it will hold a non-binding advisory vote to approve
executive compensation every Three Years, until the next
required non-binding advisory vote on the frequency of
future non-binding advisory votes to approve executive
compensation


About BIO-RAD LABORATORIES, INC. (NYSE:BIO)

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

BIO-RAD LABORATORIES, INC. (NYSE:BIO) Recent Trading Information

BIO-RAD LABORATORIES, INC. (NYSE:BIO) closed its last trading session up +0.94 at 219.20 with 291,165 shares trading hands.